Health Insurance (Section 3C Pathology –17p chromosomal deletion testing) Determination 2023
I, Daniel McCabe, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 6 June 2023
Daniel McCabe
First Assistant Secretary
Medicare Benefits and Digital Health Division
Health Resourcing Group
Department of Health and Aged Care
Contents
1. Name
2. Commencement
3. Authority
4. Definitions
5. Treatment of relevant services
6. Schedules
Schedule – relevant services
This instrument is the Health Insurance (Section 3C Pathology –17p chromosomal deletion testing) Determination 2023.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | Immediately after the commencement of Schedule 3 of the Health Insurance Legislation Amendment (2023 Measures No. 2) Determination 2023 |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.
(1) In this instrument:
Act means the Health Insurance Act 1973.
Pathology services table means the table prescribed under subsection 4A(1) of the Act.
relevant provisions means all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under the National Health Act 1953, relating to medical services, professional services or items.
relevant service means a health service, as defined in subsection 3C(8) of the Act, that is specified in a Schedule.
Schedule means a Schedule to this instrument.
Note: The following terms are defined in subsection 3(1) of the Act:
(2) Unless the contrary intention appears, a reference in this instrument to a provision of the Act or the National Health Act 1953 or regulations made under the Act or under the National Health Act 1953 as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions as in force from time to time and any other reference to provisions of an Act or regulations is a reference to those provisions as in force from time to time.
5. Treatment of relevant services
(1) For subsection 3C(1) of the Act a relevant service, provided in accordance with this Determination and as a clinically relevant service, is to be treated, for the relevant provisions, as if:
(a) it were both a professional service and a pathology service; and
(b) there were an item in Group P7 of the pathology services table that:
(i) related to the service; and
(ii) specified for the service a fee in relation to each State, being the fee specified in Schedule 1 in relation to the service.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable term in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
| ||||
Group P7—Genetics | ||||
Item | Description | Fee ($) | ||
73343 | Detection of 17p chromosomal deletions by fluorescence in situ hybridisation or genome wide micro-array, in a patient with chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node sample, requested by a specialist or consultant physician. For any particular patient at initial diagnosis, at disease relapse, or on disease progression only where initiation of, or change in therapy is anticipated. | 589.90 | ||